Amit Garg
•
I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.
181 Stories by Amit Garg
Raising a round and considering whether to do convertible or SAFE? Remember that convertible is debt that turns into equity based on certain parameters...
You have built the boat (or the rocket, or the plane, pick your favorite vehicle) and now it’s time to grow. How do you...
Excited to announce our investment alongside Arthemis in the $5M seed of Alaffia Health which uses machine learning to identify and eliminate fraud, waste,...
We are coming up to two years since COVID truly hit the US. The first three months after Mar 2020 markets were down, as...
Excited to announce our investment alongside Global Founders Capital, Softbank, Maya Capital, Canary, 10K Ventures and Grão in the oversubscribed $10M series A...
Medicine today looks drastically different than it did fifty, even ten years ago. Digital health, biotechnology, continuous sensors, the list goes on. One arena...
RockHealth supports digital health startups and their latest quarterly update suggests the VC dollars in the sector doubled and then doubled again. In other...
Excited to announce our investment in the $2M seed alongside TechU Ventures and Rhythm Ventures into Sound Health, which uses acoustic resonance to provide...
If you are asking the question then you probably already believe in the answer. Pitchbook is a company focused on analysis and research in...
Excited to announce our investment alongside KdT, Epsilon, Flare and Felicis in the $3.5M seed extension of Marigold Health. They use AI-augmented chat support...
1) Preferred vs Common Historically there have been two types of stock: preferred and common. Preferred is for investors, common for everyone else including...
Excited to announce our investment alongside Valor Capital in the R$ 45M ($8M) series A of Klivo which provides a chronic disease management platform,...
